|
|
Volumn 3, Issue 8, 2013, Pages 833-834
|
|
Seeking value as cancer drug costs soar
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GENERIC DRUG;
CANCER PATIENT;
CHRONIC MYELOID LEUKEMIA;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG INDUSTRY;
GOVERNMENT;
HUMAN;
MEDICARE;
NOTE;
REIMBURSEMENT;
ANTINEOPLASTIC AGENTS;
DELIVERY OF HEALTH CARE;
DRUG COSTS;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
UNITED STATES;
|
|
EID: 84881518656
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-ND2013-018 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
